Bond Barclay PLC 4.3% ( US06738JCC62 ) in USD

Barclay PLC

100 % ▲

United Kingdom

US06738JCC62 ( in USD )

4.3% per year ( payment 2 times a year)

19/08/2024 - Bond has expired

Prospectus brochure of the bond Barclays PLC US06738JCC62 in USD 4.3%, expired

1 000 USD

730 000 USD

06738JCC6

A ( Upper medium grade - Investment-grade )

A1 ( Upper medium grade - Investment-grade )

Barclays PLC is a British multinational banking and financial services corporation headquartered in London, offering a wide range of services including personal and corporate banking, investment banking, and wealth management.

Barclays PLC's USD 730,000, 4.3% bond (ISIN: US06738JCC62, CUSIP: 06738JCC6), issued in the UK and maturing on August 19, 2024, with a minimum trading size of USD 1,000 and a semi-annual coupon payment, has reached maturity and been redeemed at 100%, rated A by S&P and A1 by Moody's.

Pricing Supplement 14Y BARC 4.30% Survivor Option Black
Page 1 of 8
424B2 1 d424b2.htm PRICING SUPPLEMENT 14Y BARC 4.30% SURVIVOR OPTION BLACK
CALCULATION OF REGISTRATION FEE

Title of Each Class of Securities Offered

Maximum Aggregate Offering Price
Amount of Registration Fee(1)
Global Medium-Term Notes, Series A

$
730,000
$
52.05
(1) Calculated in accordance with Rule 457(r) of the Securities Act of 1933.
http://www.sec.gov/Archives/edgar/data/312070/000119312510191816/d424b2.htm
8/19/2010

Pricing Supplement 14Y BARC 4.30% Survivor Option Black
Page 2 of 8
P
(t4Idpaor
h
F
R
B
U
P
S
On
O
CS
D
B
S
F
L
Pri
T1
T icing
Te
Mao
e
A
S
er
ra
eup
o
Ag)
h i
U
Therye
a
We P
P
iled
ssuee
IN:
br
pa
icen
tal
B rs
Notesit
NNo
ro
P
30%
ssuer::
Cta
terest
SIP:
terest
yable
en
er
dd
sting:
'ot
ar
ma S
u
$730
iginal
pends
Ustyr
incipal
B
riG
incipal
r
turity
sinessi
rvivor
ght
siness
ou
oceedseupplement
spectus
spectus
suant
gistration
000
e'
pproved A
ce:
l
0Po
P
ns
nt
Ct
$730
esu
ansactionb
on
Rate
Da
to
ermitted
D
ttlement:
The
o
clays
portionr
se
ansactions N
RCLAYS
FIXED
10
a
not
nominatio
Rate:r
Od
mittedol
Issue
the
Trade
Date:
y:
r
eficial
itional
y
DN
ublic
Bda
00Cf
will
in S
te
4or
100%0 o
oR
arclaysM
DaD
A
ns:
Payment
d
C
Conv
TC;
ommi1
this R
mount:
B
0%e
Ne
ears
ollar d
rotectio
Type:
MD
ption:
exerci
otes
not
any i
ate:
n
ither
6738JCC6
wo
wner
a
dollar
onv
B
$12
apital
hese d
dated
333
ATE
Uu
F
ate:
30%n
sea
etails
ssion
claysI
be
N ated
F
ule1
ank
P
bility
S06738JCC62
Y
wi
65%
coP
m
Aerce
ugusteof
ixed
ofll
Bot1
inim
ates:
ention:
ook
045
nc
pricing9
ork
ver
Uponth
this
mounte
(1)
98
isapproveds
es August
ebruary
upplement
S$730
LC
umL
My
e
ention:n
not
ank
listed
ofd
424(b)
45845
NOTE
ugust
directly
Ra
August
of
mount t
aft S
Term1
de
N
P
$717
willoe 9
or
te1
of
try;
beL
35%nr 1
(2)
000
ntage:
6
2024
19th
ote
optiona
regarding
30/360C
9t 0
atedin
Barclays
ondon
onthlyt
5o
requestsw
total5
mmissions
hese
he1
Iffe
he
ny 6
DUE
Notes
2010
yo
2010
E
Q
by
listed
se
ir u
F
ill
Following
or
upplemento
receiveUi 2010
2009
March
Su
Bank
uro
a
the
be
xerc
indivni
se
St
initi and
1
eries
directly
nominations
O
a
provided
Un
Transferaba
curities
he
al 2010)
AUGUST
hold
rterly
sub
ises
le
nyll A
ebruaryj
dual
Survivorit
an
PLC
of
ther
s'on t
a
ect
by
es
U
commissi
orr
sale 1
heo
uch
Sad 9
s
US$1
Sem
nd
Oe
itial i
uthorized
N
to:
all
adjusted
ons
securitiests 2
pore 0
obligat0
A
xercise 2
Notes
atisf0
ption
ale
Unless4
t
y0
otesb o
ion
tion
o a
August
ys
fromfwm
o
w
holderstf
its
oc
represee
a
ee
securities
erminedN a
ndn"
het
xchange
t t
nnually
re
ofe
orurity
ny
integr
om
tative
a
D c
these
holder
e
hese
or
hat
otest I
our o
Issuer
his
n you
third
obligatio
al
AnnuofN
xchange
p p
ns
ally
mencing
t
quiredo
agent will
arty
as
mulo
he
b
scriptionr
equal
additin
y
otes
hese
quotation t
of
ricingF
h
in
o
commissis
on receive
and
they
tiples
e
S1b
benefi
ons
nformsa
o
anyf
Notes
quotatio ny
come
to
ystem U
ruary
cial
decein
n
65%sN
youat
urvivor 1
a's
of
pay
Barclayso l
S$1
9
ased
nys
supplementt east
due000
owner
be
calendar
O
ystem
the
either
is o
yptr100
paymentfi
elling t
2011
ear
ption
the
Capital o;
calenda
"
cS
I
herwise %
ib
heare
ncne
and
neficialy
bec
ruthful oe
ndl
ncipalt f
m
ea
or
or
heyour
a
thereafter
r
wcd
Notesoe
owner
urities o
ndingwa
oncessions
m principa
n
et
amount
confi l
or
another t
on
ndrhe
the
will
east
of
pletet
Eoh
xf s
e
fees
A t
mationl
Mix
o
ny
ourosfubject
Notes
repay
notet
changesi
s nclu
aturit
ay
otherle D
hose
months
ord
represet to
ate
N
$16
n
affiliateshis the
ding
otes
prior
ealer
m s
p t
50
tation
ay c
anored
y
t t
Commissiono p
pert
use
ricing itworthiness
rinc
prior
he$t t
nor
heo
da
1
his ipal
the
te
any
p of
000s
contr
ri p
a r
the
tate
ry
cing
supplement o
r
princi
isisf
Maturia
sup Barclays
otection
ty
palc
p
b a
le p
Date
equest
mount
securities
riminal
ment
eing us Bank
rovided
follo
o
in
ed in a
w
and tin
a PLC
m
g
m
ffense t
marketh
ay
commission e T
d
has
arket he
aturity
era
resalet
retainh o
all f
esale
http://www.sec.gov/Archives/edgar/data/312070/000119312510191816/d424b2.htm
8/19/2010

Pricing Supplement 14Y BARC 4.30% Survivor Option Black
Page 3 of 8
The Notes constitute our direct, unconditional, unsecured and unsubordinated obligations and are not deposit liabilities of
Barclays Bank PLC and are not insured by the U.S. Federal Deposit Insurance Corporation or any other governmental
agency of the United States, the United Kingdom or any other jurisdiction.
Investing in the Notes involves a number of risks. See "Risk Factors" beginning on page S-5 of the prospectus supplement and
"Selected Risk Factors" below. We urge you to consult your investment, legal, tax, accounting and other advisers and to invest
in the Notes only after you and your advisors have carefully considered the suitability of an investment in the Notes in light of
your particular circumstances.
Barclays Bank PLC has filed a registration statement (including a prospectus) with the SEC for the offering to which this
pricing supplement relates. Before you invest, you should read the prospectus dated February 10, 2009, the prospectus
supplement dated March 1, 2010, and other documents Barclays Bank PLC has filed with the SEC for more complete
information about Barclays Bank PLC. and this offering. Buyers should rely upon this pricing supplement, the prospectus, the
prospectus supplement, and any relevant free writing prospectus for complete details. You may get these documents and other
documents Barclays Bank PLC has filed for free by visiting EDGAR on the SEC website at www.sec.gov, and you may also
access the prospectus and prospectus supplement through the links below:

·
Prospectus dated February 10, 2009:
http://www.sec.gov/Archives/edgar/data/312070/000119312509023285/dposasr.htm

·
Prospectus Supplement dated March 1, 2010:
http://www.sec.gov/Archives/edgar/data/312070/000119312510043357/d424b3.htm
Our Central Index Key, or CIK, on the SEC website is 1-10257.
Alternatively, Barclays Capital Inc. or any agent or dealer participating in this offering will arrange to send you this pricing
supplement, the prospectus, the prospectus supplement and any related free writing prospectus if you request it by calling
your Barclays Capital Inc. sales representative, such dealer or 1-888-227-2275 (Extension 2-3430). A copy of the prospectus
may be obtained from Barclays Capital Inc., 745 Seventh Avenue--Attn: US InvSol Support, New York, NY 10019.
You may revoke your offer to purchase the Notes at any time prior to the time at which we accept such offer by notifying the
applicable agent. We reserve the right to change the terms of, or reject any offer to purchase the Notes prior to their issuance. In the
event of any changes to the terms of the Notes, we will notify you and you will be asked to accept such changes in connection with
your purchase. You may also choose to reject such changes in which case we may reject your offer to purchase.
As used in this term sheet, the "Company," "we," "us," or "our" refers to Barclays Bank PLC.
http://www.sec.gov/Archives/edgar/data/312070/000119312510191816/d424b2.htm
8/19/2010

Pricing Supplement 14Y BARC 4.30% Survivor Option Black
Page 4 of 8
SELECTED RISK FACTORS
An investment in the Notes involves significant risks. You should read the risks summarized below in connection with, and the
risks summarized below are qualified by reference to, the risks described in more detail in the "Risk Factors" section
beginning on page S-5 of the prospectus supplement. We urge you to consult your investment, legal, tax, accounting and other
advisers and to invest in the Notes only after you and your advisors have carefully considered the suitability of an investment
in the Notes in light of your particular circumstances.

·
Issuer Credit Risk--The Notes are our unsecured debt obligations, and are not, either directly or indirectly, an
obligation of any third party. Any payment to be made on the Notes, including any principal protection provided at
maturity, depends on our ability to satisfy our obligations as they come due. As a result, the actual and perceived

creditworthiness of Barclays Bank PLC may affect the market value of the Notes and, in the event we were to default
on our obligations, you may not receive the principal protection or any other amounts owed to you under the terms of
the Notes.

·
Certain Built-In Costs Are Likely to Adversely Affect the Value of the Notes Prior to Maturity--Although you
will not receive less than the principal amount of the Notes if you hold the Notes to maturity (subject to Issuer credit
risk), the Original Issue Price of the Notes includes the agent's commission and the cost of hedging our obligations

under the Notes through one or more of our affiliates. As a result, assuming no change in market conditions or any
other relevant factor, the price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC will
be willing to purchase Notes from you in secondary market transactions may be lower than the Original Issue Price,
and any sale prior to the Maturity Date could result in a substantial loss to you.

·
Potential Conflicts--We and our affiliates play a variety of roles in connection with the issuance of the Notes,

including hedging our obligations under the Notes. In performing these duties, the economic interests of our
affiliates of ours are potentially adverse to your interests as an investor in the Notes.
In addition, Barclays Wealth, the wealth management division of Barclays Capital Inc., may arrange for the sale of
the Notes to certain of its clients. In doing so, Barclays Wealth will be acting as agent for Barclays Bank PLC and
may receive compensation from Barclays Bank PLC in the form of discounts and commissions. The role of Barclays
Wealth as a provider of certain services to such customers and as agent for Barclays Bank PLC in connection with
the distribution of the Notes to investors may create a potential conflict of interest, which may be adverse to such
clients. Barclays Wealth is not acting as your agent or investment adviser, and is not representing you in any capacity
with respect to any purchase of Notes by you. Barclays Wealth is acting solely as agent for Barclays Bank PLC. If
you are considering whether to invest in the Notes through Barclays Wealth, we strongly urge you to seek
independent financial and investment advice to assess the merits of such investment.

·
Lack of Liquidity--The Notes will not be listed on any securities exchange. Barclays Capital Inc. and other
affiliates of Barclays Bank PLC intend to make a secondary market for the Notes but are not required to do so, and
may discontinue any such secondary market making at any time, without notice. Even if there is a secondary market,
it may not provide enough liquidity to allow you to trade or sell the Notes easily. Because other dealers are not likely

to make a secondary market for the Notes, the price at which you may be able to trade your Notes is likely to depend
on the price, if any, at which Barclays Capital Inc. and other affiliates of Barclays Bank PLC are willing to buy the
Notes. The Notes are not designed to be short-term trading instruments. Accordingly, you should be able and willing
to hold your Notes to maturity.

·
Many Economic and Market Factors Will Impact the Value of the Notes--The value of the Notes will be

affected by a number of economic and market factors that may either offset or magnify each other, including:

· the time to maturity of the Notes;

· interest and yield rates in the market generally;

· a variety of economic, financial, political, regulatory or judicial events; and

· our creditworthiness, including actual or anticipated downgrades in our credit ratings.

PS1
http://www.sec.gov/Archives/edgar/data/312070/000119312510191816/d424b2.htm
8/19/2010

Pricing Supplement 14Y BARC 4.30% Survivor Option Black
Page 5 of 8
DESCRIPTION OF SURVIVOR'S OPTION
Upon request by the authorized representative of the beneficial owner of the Notes, Barclays Bank PLC will repay those Notes prior to
the Maturity Date following the death of the beneficial owner of the Notes (the "Survivor's Option"), provided such Notes were
acquired by the deceased beneficial owner at least six months prior to the date of the request. Upon the valid exercise of the Survivor's
Option and the proper tender of the Notes for repayment, Barclays Bank PLC will repay such Notes, in whole or in part, at a price
equal to 100% of the principal amount of the deceased beneficial owner's beneficial interest in the Notes plus accrued and unpaid
interest to the date of repayment. For purposes of this section, a beneficial owner of Notes is a person who has the right, immediately
prior to such person's death, to receive the proceeds from the disposition of such Notes, as well as the right to receive payment of the
principal of the Notes.
To be valid, the Survivor's Option must be exercised by or on behalf of the person who has authority to act on behalf of the deceased
beneficial owner of the Notes under the laws of the applicable jurisdiction (including, without limitation, the personal representative of
or the executor of the estate of the deceased beneficial owner or the surviving joint owner with the deceased beneficial owner).
The death of a person holding a beneficial ownership interest in the Notes: (1) with any person in a joint tenancy with right of
survivorship; or (2) with his or her spouse in tenancy by the entirety, tenancy in common, as community property or in any other joint
ownership arrangement, will be deemed the death of a beneficial owner of those Notes, and the entire principal amount of the Notes
held in this manner will be subject to repayment by Barclays Bank PLC upon request. However, the death of a person holding a
beneficial ownership interest in Notes as tenant in common with a person other than his or her spouse will be deemed the death of a
beneficial owner only with respect to such deceased person's interest in the Notes, and only the deceased beneficial owner's
percentage interest in the principal amount of the Notes will be subject to repayment.
If the ownership interest in the Notes is held by a nominee for a beneficial owner or by a custodian under a Uniform Gifts to Minors
Act or Uniform Transfer to Minors Act, or by a trustee of a trust that is wholly revocable by the beneficial owner, or by a guardian or
committee for a beneficial owner, the death of the beneficial owner of the Notes will constitute death of the beneficial owner for
purposes of the Survivor's Option, if the beneficial ownership interest can be established to the satisfaction of Barclays Bank PLC. In
these cases, the death of the nominee, custodian, trustee, guardian or committee will not be deemed the death of the beneficial owner
of the Notes for purposes of the Survivor's Option.
Barclays Bank PLC has the discretionary right to limit the aggregate principal amount of the Notes as to which exercises of the
Survivor's Option will be accepted by it from all authorized representatives of deceased beneficial owners in any calendar year, to an
amount equal to 2.0% of the aggregate amount of the Notes, outstanding as of the end of the most recent calendar year.
Barclays Bank PLC also has the discretionary right to limit to $250,000 the aggregate principal amount of Notes as to which exercises
of the Survivor's Option will be accepted by Barclays Bank PLC from the authorized representative for any individual deceased
beneficial owner of such notes in any calendar year. In addition, Barclays Bank PLC will not permit the exercise of the Survivor's
Option (a) for a principal amount less than $1,000, or (b) if such exercise will result in a beneficial ownership interest in a note with a
principal amount of less than $1,000 outstanding.
An otherwise valid election to exercise the Survivor's Option may not be withdrawn. Elections to exercise the Survivor's Option will
be accepted in the order that they are received and approved by Barclays Bank PLC, except for any election the acceptance of which
would contravene any of the limitations described above. Notes accepted for repayment through the exercise of the Survivor's Option
will be repaid on the first Interest Payment Date that occurs 60 or more calendar days after the date of the acceptance and approval by
Barclays Bank PLC. Each tendered Note that is not accepted in any calendar year due to the application of any of the limitations
described in the preceding paragraph will be deemed to be tendered in the following calendar year in the order in which all such Notes
were originally tendered. If a Note tendered through a valid exercise of the Survivor's Option is not accepted by Barclays Bank PLC,
the trustee, upon receipt of a valid written instruction from Barclays Bank PLC or its agent, will deliver a notice to the registered
holder that states the reason that Note has not been accepted for repayment.
Because the Notes will be issued in book-entry form (except in very limited circumstances), DTC or its nominee will be treated as the
holder of the Notes, will be the only entity that receives notices from Barclays Bank PLC (or the trustee) and, on behalf of the
deceased beneficial owner's authorized representative, will be the only entity that can exercise the Survivor's Option for such Notes.
To obtain repayment of the Notes pursuant to exercise of the Survivor's Option, the deceased beneficial owner's authorized
representative must provide the following items to the broker or other entity through which the beneficial interest in the Notes is held
by the deceased beneficial owner:

·
appropriate evidence satisfactory to Barclays Bank PLC that:

(1) the deceased was the beneficial owner of the Notes at the time of death and his or her interest in the Notes was

acquired by the deceased beneficial owner at least six months prior to the request for repayment,

(2) the death of the beneficial owner has occurred and the date of death, and
http://www.sec.gov/Archives/edgar/data/312070/000119312510191816/d424b2.htm
8/19/2010

Pricing Supplement 14Y BARC 4.30% Survivor Option Black
Page 6 of 8

(3) the representative has authority to act on behalf of the deceased beneficial owner;

·
if the beneficial interest in the Notes is held by a nominee or trustee of, custodian for, or other person in a similar

capacity to, the deceased beneficial owner, evidence satisfactory to Barclays Bank PLC from the nominee, trustee,
custodian or similar person attesting to the deceased's beneficial ownership of that Notes;

·
a written request for repayment signed by the authorized representative of the deceased beneficial owner with the
signature guaranteed by a firm that is a participant in the Security Transfer Agents Medallion Program, the New

York Stock Exchange Medallion Signature Program or the Stock Exchange Medallion Program (generally a member
of a registered national securities exchange, a member of the Financial Industry Regulatory Authority, or a
commercial bank or trust company having an office in the United States);

·
tax waivers and any other instruments or documents that Barclays Bank PLC reasonably requires in order to

establish the validity of the beneficial ownership of the Notes and the claimant's entitlement to payment; and

·
any additional information Barclays Bank PLC requires to evidence satisfaction of any conditions to the exercise of

the Survivor's Option or to document beneficial ownership or authority to make the election and to cause the
repayment of the Notes.
In turn, the broker or other entity will deliver each of these items, through the appropriate direct participant in DTC and the facilities
of DTC will deliver the Survivor's Option form of notice (the "Form of Notice"), to the trustee and to Barclays Bank PLC and will
certify to Barclays Bank PLC that the broker or other entity represents the deceased beneficial owner. The broker or other entity will
be responsible for disbursing payments received from the trustee, through the facilities of DTC, to the authorized representative.
During any time in which the Notes are not represented by a global note and are issued in definitive form:

· all references in this section to participants and DTC, including the DTC's governing rules, regulations and procedures, will

be deemed inapplicable;

· all determinations that the DTC participants are required to make as described in this section will be made by Barclays
Bank PLC, including, without limitation, determining whether the applicable decedent is in fact the beneficial owner of the

interest in the Notes to be redeemed or is in fact deceased and whether the representative is duly authorized to request
redemption on behalf of the applicable beneficial owner; and

· all redemption requests, to be effective, must:

· be delivered by the representative to Barclays Bank PLC and to the trustee;

· be made by completing the Form of Notice in accordance with the related instructions; and

· be accompanied by, if applicable, a properly executed assignment or endorsement, in addition to all documents
that are otherwise required to accompany a redemption request. If the record holder of the Note is a nominee of

the deceased beneficial owner, a certificate or letter from the nominee attesting to the deceased's ownership of
a beneficial interest in the Note must also be delivered.
Barclays Bank PLC retains the right to limit the aggregate principal amount of Notes as to which exercises of the Survivor's Option
will be accepted from all authorized representatives of deceased beneficial owners and from the authorized representative for any
individual deceased beneficial owner in any one calendar year as described above. All other questions regarding the eligibility or
validity of any exercise of the Survivor's Option generally will be determined by Barclays Bank PLC, which determination will be
final and binding on all parties.
The Form of Notice may be obtained from Barclays Bank PLC, 745 Seventh Avenue, New York, NY 10019, Attention: US-
Syndicate, MTN Desk US, telephone: 212-412-1535.
UNITED STATES FEDERAL INCOME TAX TREATMENT
The following discussion supplements the discussion in the prospectus supplement under the heading "Certain U.S. Federal Income
Tax Considerations" and supersedes it to the extent inconsistent therewith. The following discussion (in conjunction with the
discussion in the prospectus supplement) summarizes certain of the material U.S. federal income tax consequences of the purchase,
beneficial ownership, and disposition of the Notes.
We intend to treat the Notes as indebtedness for U.S. federal income tax purposes and any reports to the Internal Revenue Service (the
"IRS") and U.S. holders will be consistent with such treatment, and each holder will agree to treat the Notes as indebtedness for U.S.
federal income tax purposes. The discussion that follows is based on this approach.
http://www.sec.gov/Archives/edgar/data/312070/000119312510191816/d424b2.htm
8/19/2010

Pricing Supplement 14Y BARC 4.30% Survivor Option Black
Page 7 of 8
Interest paid on the Notes will be taxable to a U.S. holder as ordinary interest income at the time it accrues or is received in
accordance with the U.S. holder's normal method of accounting for tax purposes. See "U.S. Federal Income Tax Considerations--
Payments of Interest" in the prospectus supplement.
3.8% Medicare Tax On "Net Investment Income"
Beginning in 2013, U.S. holders that are individuals, estates, and certain trusts will be subject to an additional 3.8% tax on all or a
portion of their "net investment income," which may include the interest payments and any gain realized with respect to the Notes, to
the extent of their net investment income that when added to their other modified adjusted gross income, exceeds $200,000 for an
unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), or $125,000 for a married
individual filing a separate return. U.S. holders should consult their advisors with respect to their consequences with respect to the
3.8% Medicare tax.
Information Reporting
Holders that are individuals (and, to the extent provided in future regulations, entities) may be subject to reporting obligations
applicable to certain foreign financial assets with respect to their Notes if the aggregate value of their Notes and their other "specified
foreign financial assets" exceeds $50,000. Significant penalties can apply if a holder fails to disclose its specified foreign financial
assets. This information reporting requirement is generally applicable for taxable years beginning after March 18, 2010. We urge you
to consult your tax advisor with respect to this and other reporting obligations with respect to your Notes.
CERTAIN EMPLOYEE RETIREMENT INCOME SECURITY ACT CONSIDERATIONS
Your purchase of a Note in an Individual Retirement Account (an "IRA"), will be deemed to be a representation and warranty by you,
as a fiduciary of the IRA and also on behalf of the IRA, that (i) neither the issuer, the placement agent nor any of their respective
affiliates has or exercises any discretionary authority or control or acts in a fiduciary capacity with respect to the IRA assets used to
purchase the Note or renders investment advice (within the meaning of Section 3(21)(A)(ii) of the Employee Retirement Income
Security Act ("ERISA")) with respect to any such IRA assets and (ii) in connection with the purchase of the Note, the IRA will pay no
more than "adequate consideration" (within the meaning of Section 408(b)(17) of ERISA) and in connection with any redemption of
the Note pursuant to its terms will receive at least adequate consideration, and, in making the foregoing representations and warranties,
you have (x) applied sound business principles in determining whether fair market value will be paid, and (y) made such
determination acting in good faith.
For additional ERISA considerations, see "Employee Retirement Income Security Act" in the prospectus supplement.
SUPPLEMENTAL PLAN OF DISTRIBUTION
We have agreed to sell to Barclays Capital Inc. (the "Agent"), and the Agent has agreed to purchase from us, the principal amount of
the Notes, and at the price, specified on the cover of this pricing supplement. The Agent is committed to take and pay for all of the
Notes, if any are taken.
http://www.sec.gov/Archives/edgar/data/312070/000119312510191816/d424b2.htm
8/19/2010

Pricing Supplement 14Y BARC 4.30% Survivor Option Black
Page 8 of 8

US$730,000
BARCLAYS BANK PLC
4.30% FIXED RATE NOTES DUE AUGUST 19, 2024
GLOBAL MEDIUM-TERM NOTES, SERIES A
(TO PROSPECTUS DATED FEBRUARY 10, 2009, AND THE
PROSPECTUS SUPPLEMENT DATED MARCH 1, 2010)

http://www.sec.gov/Archives/edgar/data/312070/000119312510191816/d424b2.htm
8/19/2010